1Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer [J]. N EnglJ Med, 1994, 330(9): 592-596
2Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: a review of the literature[J].J Pain Symptom Manage, 1999,18(5):358-368
3Berger A, Dukes E, Smith M, et al. Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life[J].J Pain Symptom Manage, 2003, 26(2): 723-730
4Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium[J]. Drugs, 2001, 61(7): 955-977
5Broomhead A, Kerr R, Tester W, et al. Comparison of a oncea-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain [J]. J Pain Symptom Manage,1997, 14(2): 63-73
6Kest B, Sarton E, Dahan A. Gender differences in opioid-mediated analgesia: animal and human studies [J]. Anesthesiology, 2000,93(2): 539-547
7Sarton E, Olofsen E, Romberg R, et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers [J].Anesthesiology, 2000, 93 (5): 1245-1254
8Fillingim RB, Gear RW. Sex differences in opioid analgesia: clinical and experimental findings[J]. EurJ Pain, 2004, 8(5): 413-425
9Vigano A, Bruera E, Suarez-Almazor ME. Age, pain intensity,and opioid dose in patients with advanced cancer [J]. Cancer,1998, 83(6): 1244-1250
10Bercovitch M, Adunsky A. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it[J]?Cancer, 2004, 101(6): 1473-1477
